Spanning 20+ countries across five continents, with headquarters in India, our subsidiaries power seamless operations from sales and marketing to logistics and commercialization.
We efficiently serve both emerging and developed markets, navigating regulated, semi-regulated, and non-regulated environments with ease. With 250+ product registrations, we continue to deliver quality healthcare solutions across diverse geographies, reinforcing our commitment to innovation and accessibility.
By combining strong partnerships with deep local expertise, we’re not just entering markets; we are transforming access to life-saving therapies.
We believe in delivering excellence through quality, compliance, and innovation, supported by all necessary regulatory approvals:
USFDA – Our facilities and processes are approved by the U.S. Food & Drug Administration, ensuring compliance with one of the world’s most stringent regulatory frameworks for safety, efficacy, and quality.
MHRA – Caritas adheres to the rigorous standards set by the Medicines and Healthcare Products Regulatory Agency, affirming our commitment to global best practices in pharmaceutical manufacturing.
ANVISA (Brazil) – Approval from ANVISA, Brazil’s regulatory authority, reflects our dedication to meeting high-quality benchmarks in Latin America’s largest healthcare market.
EU-GMP – With European Union Good Manufacturing Practice (EU-GMP) certification, Caritas guarantees products manufactured to internationally recognized quality and safety standards.
Caritas partners with six world-class manufacturing plants across India, equipped with cutting-edge technology to deliver a wide spectrum of pharmaceutical solutions.
From tablets, capsules, syrups, and suspensions to high-precision injectables, liquid ampoules, and vials, products are engineered with unmatched scale, speed, and accuracy in state-of-the-art facilities.
With plants located in India’s leading pharma hubs, Caritas is strategically positioned to serve global markets with efficiency and speed.
Every plant adheres to stringent QA/QC systems that are aligned with global best practices. From raw material to final packaging, every stage undergoes rigorous testing to guarantee safety and quality.
Patient safety is our top priority. We have a robust pharmacovigilance system to monitor, assess, and prevent adverse events throughout the lifecycle of our medicines. By working with healthcare providers, regulators, and patients, we continuously evaluate real-world data to identify risks early and take proactive safety measures.
Our goal is not only compliance with global regulations but also fostering a culture of vigilance, accountability, and care—so that every therapy we deliver meets the highest standards of safety and quality. If you have experienced or observed any adverse event or safety concern, please report it here:
Caritas manages end-to-end global logistics through integrated sales, marketing, warehousing, and distribution networks. With subsidiaries in Mexico, Ecuador, Singapore, the Dominican Republic, the Philippines, Guatemala, Kenya, Uganda, & Tanzania, we drive full business operations, including regulatory, commercialization, and supply chain management.
Our strategic warehouses in Mexico, Ecuador, and India ensure faster market access, while strong distribution channels provide seamless reach in both private and public (tender) markets. Backed by local teams in each country and 25+ years of international expertise, Caritas ensures that high-quality medicines are delivered efficiently, compliantly, and with a customer-first approach.